Downregulation of CDC42 inhibits the proliferation and stemness of human trophoblast stem cell via EZRIN/YAP inactivation.
Bi ShileiZhang LiziHuang LijunMa WeixuMeng NanDeng WeinanLi YulianLiang YingyuHuang MinshanXu PeiLiu MingxingChen JingsiTu ZhaoweiWang ZhijianWang HaibinLu JinhuaChen DunjinLili DuPublished in: Cell and tissue research (2022)
Placental dysplasia increases the risk of recurrent spontaneous abortion (RSA). However, the underlying mechanism regulating placental development remains unclear. In this study, we showed that the expression of CDC42 was decreased in the villous tissue of RSA samples compared to healthy controls. Further examination demonstrated that CDC42 deficiency led to the differentiation of human trophoblast stem cells (hTSCs) and inhibited their proliferation. Genetic manipulation of YAP and EZRIN in hTSCs revealed that CDC42 regulates the stemness and proliferation of hTSCs; this is dependent on EZRIN, which translocates YAP into the nucleus. Moreover, the expression pattern of EZRIN, YAP, and Ki67 was also abnormal in the villous tissue of RSA samples, consistent with in vitro experiments. In summary, these findings suggest that the CDC42/EZRIN/YAP pathway plays an important role in placental development.
Keyphrases
- stem cells
- cell cycle
- signaling pathway
- endothelial cells
- poor prognosis
- cell proliferation
- epithelial mesenchymal transition
- induced pluripotent stem cells
- cell therapy
- binding protein
- single cell
- genome wide
- bone marrow
- gene expression
- radiation therapy
- neoadjuvant chemotherapy
- mesenchymal stem cells
- rectal cancer